Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
99,963,154
-
Total 13F shares
-
89,723,577
-
Share change
-
+1,404,667
-
Total reported value
-
$8,083,967,833
-
Put/Call ratio
-
94%
-
Price per share
-
$90.11
-
Number of holders
-
326
-
Value change
-
+$131,837,632
-
Number of buys
-
178
-
Number of sells
-
134
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) as of Q3 2019
As of 30 Sep 2019,
NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) was held by
326 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
89,723,577 shares.
The largest 10 holders included
FMR LLC, JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Capital International Investors, PERCEPTIVE ADVISORS LLC, Bellevue Group AG, FRANKLIN RESOURCES INC, and STATE STREET CORP.
This page lists
326
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.